Poolbeg Pharma (LSE:POLB) Other Income (Expense) : £-0.35 Mil (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Poolbeg Pharma Other Income (Expense)?

Poolbeg Pharma's other income expense for the Poolbeg Pharma's pretax income for the six months ended in Jun. 2024 was £0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2024 was £-0.35 Mil.

Poolbeg Pharma Other Income (Expense) Historical Data

The historical data trend for Poolbeg Pharma's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poolbeg Pharma Other Income (Expense) Chart

Poolbeg Pharma Annual Data

Trend

Dec21

Dec22

Dec23

Other Income (Expense)

-0.35

Poolbeg Pharma Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Other Income (Expense)	Get a 7-Day Free Trial			-	-	-	-0.35	-

Poolbeg Pharma Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.35 Mil.

Poolbeg Pharma (LSE:POLB) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Poolbeg Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poolbeg Pharma PLC (LSE:POLB) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

7JN:Germany

Address

42 New Road, Queen Mary BioEnterprises Innovation Centre, London, GBR, E1 2AX

Website

https://www.poolbegpharma.com

Poolbeg Pharma PLC is a clinical-stage infectious disease pharmaceutical company, with a novel capital-light clinical model which enables to develop of multiple products faster and more cost-effectively than the traditional biotech model. The company aspires to become a one-stop shop for pharma-seeking mid-stage products to license or acquire.

Poolbeg Pharma Headlines

No Headlines